Tempo Wealth’s Pfizer PFE Stock Holding History

Tempo Wealth’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$215K	Buy	8,923 +322	+4%	+$8.42K	0.03%	223
2026 Q1	$242K	Sell	8,601 -130	-1%	-$3.46K	0.04%	195
2025 Q4	$217K	Buy	+8,731	New	+$220K	0.04%	199

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Tempo Wealth's PFE Position: Q2 2026 in Review

Tempo Wealth increased its Pfizer (PFE) stake by 3.7% in Q2 2026, buying an estimated $8.42K and bringing the position to 8,923 shares worth $215K. The position accounts for 0.03% of the portfolio, ranked #223.

Tempo Wealth first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $242K in Q1 2026. 2,814 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Tempo Wealth held 8,923 shares of Pfizer worth $215K as of Q2 2026.
Tempo Wealth bought 322 Pfizer shares in Q2 2026, an estimated $8.42K.
Pfizer made up 0.03% of Tempo Wealth's portfolio in Q2 2026, its #223 holding.
Tempo Wealth first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
Tempo Wealth's Pfizer position peaked at $242K in Q1 2026.
2,814 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Tempo Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.